Abstract
In the perioperative management of patients on long-term oral anticoagulant (OAC) therapy the problem is balancing the thromboembolic (TER) and the haemorrhagic risk (HR) in the perioperative period. The Federazione Centri per la diagnosi della trombosi e la Sorveglianza delle terapie Antitrombotiche (FCSA) activated an online registry from November 2001 to August 2003 in order to collect information on the management of these patients in Italy. Four hundred and eleven patients, undergoing elective major (18%) and minor surgery (82%), from 7 centres, were registered. Three hundred and ninety-nine out of 411 patients received LMWH either once a day (310 patients) or twice a day (89 patients) during OAC therapy discontinuation. Two thromboembolic (0.48%) and 16 bleeding events (7 major; 1.7%) were reported. Notwithstanding the lower doses of heparin (54.3 U/kg o.d. and 64.4 U/kg b.i.d.), the thromboembolic complications are in line with those reported in the literature. The data of this study suggest that the intervention with LMWH may be relevant only in the high-risk patients as already proposed by others.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kearon C, Hirsh J (1997) Managing anticoagulation before and after surgery in patients who require oral anticoagulants. N Engl J Med 336:1506–1511
Heit JA (2001) Perioperative management of the chronically anticoagulated patient. J Thromb Thrombolysis 12:81–87
Douketis JD (2003) Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinician. Thromb Res 108:3–12
Watts SA, Gibbs NM (2003) Outpatient management of the chronically anticoagulated patient for elective surgery. Anaesth Intensive Care 31:145–154
Mannucci C, Douketis JD (2006) The management of patients who require temporary reversal of vitamin K antagonist for surgery: a practical guide for clinicians. Intern Emerg Med 1:96–104
Spyropoulos AC, Turpie AGG (2005) Perioperative bridging interruption with heparin for the patient receiving long-term anticoagulation. Curr Opin Pulm Med 11:373–379
Kearon C (2003) Management of anticoagulation before and after elective surgery. Hematology 528–539
Kearon C, Hirsh J (1997) Anticoagulation and elective surgery. N Engl J Med 337:938–940
Garcia D, Hylek E (2006) Risk of thromboembolism after short-term interruption of warfarin. Blood 108:abs 625
Ansell J, Poller L, Bussey H et al (2004) The pharmacology and management of vitamin K antagonists. The seventh ACCP conference on anticoagulation and thrombotic therapy. Chest 126:S204–S233
British Committee for Standards in Haematology (1998) Guidelines on oral anticoagulation, 3rd Edn. Br J Haematol 101:374–387
Baglin TP, Keeling DM, Watson HG for the British Committee for Standards in Haematology (2005) Guidelines on oral anticoagulation (warfarin): third edition — 2005 update. Br J Haematol 132:277–285
Palareti G, Leali N, Coccheri S et al (1996) Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 348:423–428
Ageno W, Garcia D, Libby E, Crowther MA (2004) Managing oral anticoagulant therapy in patients with mechanical heart valves undergoing elective surgery: results of a survey conducted among Italian physicians. Blood Coag Fibrin 15:623–628
Kirtane AJ, Rahman AM, Martinezclark P et al (2006) Adherence to American College of Cardiology/American Heart Association guidelines for the management of anticoagulation in patients with mechanical valves undergoing elective outpatient procedures. Am J Cardiol 97:891–893
Douketis JD, Johnson JA, Turpie AG (2004) Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin. Assessment of a standardized periprocedural anticoagulant regimen. Arch Intern Med 164:1391–1326
Kovacs M, Kahn S, Solymoss S et al (2004) Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary discontinuation of warfarin. Circulation 110:1658–1663
Dunn AS, Spyropoulos AC, Sirko SP, Turpie AGG (2004) Perioperative bridging therapy with enoxaparin in patients requiring interruption of long-term oral anticoagulant therapy: a multicenter cohort study. Blood 104:488a
Douketis JD, Johnson JA, Turpie AG (2004) Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin. Assessment of a standardized periprocedural anticoagulation regimen. Arch Intern Med 164:1319–1326
Malato A, Anastasio R, Cigna V et al (2006) Perioperative bridging therapy with low molecular weight heparin in patients requiring interruption of long-term oral anticoagulant therapy. Haematologica 91:10
Spyropoulos AC, Turpie AGG, Dunn AS et al for the REGIMEN investigators (2006) Low-molecular-weight heparin or unfractionated heparin as bridging therapy in patients on long-term oral anticoagulants: results from the REGIMEN registry. J Thromb Haemost 4:1246–1252
Author information
Authors and Affiliations
Corresponding author
Additional information
on behalf of Federazione Centri per la diagnosi della trombosi e la Sorveglianza delle terapie Antitrombotiche (FCSA)
Rights and permissions
About this article
Cite this article
Baudo, F., de Cataldo, F., Mostarda, G. et al. Management of patients on long-term oral anticoagulant therapy undergoing elective surgery: survey of the clinical practice in the Italian anticoagulation clinics. Int Emergency Med 2, 280–284 (2007). https://doi.org/10.1007/s11739-007-0078-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-007-0078-y